Information  X 
Enter a valid email address

Baillie Gifford Shin (BGS)

  Print      Mail a friend

Friday 17 May, 2019

Baillie Gifford Shin

AGM Statement

RNS Number : 4625Z
Baillie Gifford Shin Nippon PLC
17 May 2019


Legal Entity Identifier: X5XCIPCJQCSUF8H1FU83

Annual General Meeting, 17 May 2019


All resolutions were passed at the AGM of the Company held on 17 May 2019, including those detailed below:

Special Business

·    Shareholders approved an ordinary resolution approving the adoption of the proposed investment policy as set out in the Annual Report and Financial Statements.

Ordinary Business

·    Shareholders approved an ordinary resolution renewing the Directors' general authority to issue shares up to an aggregate nominal amount of £1,833,666.50 and a special resolution to allot a limited number of shares for cash on a non pre-emptive basis up to £550,154.96 (being approximately 10% of the nominal value of the issued share capital of the Company).  These authorities will expire at the earlier of 17 August 2020 or at the conclusion of the next Annual General Meeting of the Company, unless previously varied, revoked or renewed.

·    Shareholders approved a special resolution authorising the Company to buy-back its own shares up to a maximum of 14.99% of the Company's issued share capital, being 41,234,115 ordinary shares of 2p. This authority will expire at the conclusion of the AGM to be held in respect of the year ending 31 January 2020 unless previously varied, revoked or renewed.


The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism at

Baillie Gifford & Co Limited

Company Secretaries

17 May 2019



Regulated Information Classification: Additional regulated information required to be disclosed under the laws of a Member State of the European Union


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t